Novartis sells flu vaccines, Holly Springs facility to Australian-based CSL for $275M - Triangle Business Journal
US declares Seqirus Holly Springs 'pandemic ready' to produce 150 million doses of flu vaccine in NC - Research Triangle Regional Partnership
Seqirus' Holly Springs Manufacturing Facility Designated as 'Pandemic Ready' - Infectious Disease Special Edition
Seqirus Investing $140M In North Carolina Expansion - Research Triangle Regional Partnership
Seqirus joins Big Pharma competitors in quadrivalent flu vax arena | Fierce Pharma
Seqirus readies for $9M expansion project in Holly Springs - Triangle Business Journal
Seqirus Vaccine Manufacturing Facility Expansion, Holly Springs, NC
Seqirus By Steven Roberts | Suburban Living Magazine
CSL Seqirus Manufacturing
CSL Seqirus | Manufacturing Technologies
CSL to build $800m flu vaccine facility in Melbourne
New Flu Vaccine from Holly Springs Gets FDA Green Light | North Carolina Biotechnology Center
Seqirus Vaccine Manufacturing Facility Expansion, Holly Springs, NC
Seqirus Investing $140M In Holly Springs, North Carolina Expansion
Seqirus Begins Shipping 2017-2018 Influenza Vaccines to the U.S. Market | Business Wire
CSL Seqirus | Partnership Opportunities
Seqirus Begins Shipping 2018-2019 Influenza Vaccines to the U.S. Market
Seqirus Starts $9M Expansion of Vaccine Plant | NC Biotech
Seqirus - BE&K Building Group
Life Sciences to Rent, Catalyst BioCampus, Holly Springs New Hill Road, 27540 - CBRE Commercial
Daniel Lee - QC Manager, Compliance/Logistics - CSL Seqirus | LinkedIn
CSL Seqirus Manufacturing
World-Leading Seqirus Flu Vax Factory in NC Makes History -- Again | North Carolina Biotechnology Center
DPR Construction | Seqirus cGMP Warehouse Expansion
Seqirus 4-in-1 flu shot for children manufactured at Holly Springs plant
Seqirus in Search of Next-Generation Flu Vaccines | North Carolina Biotechnology Center
